IRCT20220211053992N6招募中未知
In vivo Bioequivalence study of Aspirin 81mg tablet manufactured by Aani Darman Pharmaceutical Co. Compared to innovator Product
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 59 years（—）
- 性别
- Male
入选标准
- •General Health (in terms of Liver, Heart and Kidney diseases)
- •Age between 18 to 60 years
排除标准
- •History of cardiovascular, liver, and kidney disease
- •Alcohol and drug addiction
- •History of drug allergy
研究者
相似试验
招募中
Unknown
In vivo Bioequivalence study of Aspirin tabletIRCT20220211053992N20Tabriz University of Medical Sciences24
招募中
不适用
Aspirin tablets 81mg (ASPIRIN® 81mg) Kharazmi , In- Vivo Bioequivalence in Iranian healthy volunteers.IRCT20200105046010N10Tabriz University of Medical Sciences24
已完成
不适用
Comparative in vivo evaluation of 2 Aspirin 81 mg Enteric-coated Tablet formulations.IRCT20180620040164N33Actover Pharmaceutical Co.24
招募中
3 期
Effectiveness of Aspirin 80, Aspirin 325, Enoxaparin and Rivoroxaban in Prevention of Coagulopathy after Total Knee ArthroplastyIRCT20181128041784N1Hamedan University of Medical Sciences124
招募中
Unknown
In-vivo Bioequivalence Study of ASA 80 mg EC Tablet of The Test Drug (Sajjad Darou, Iran)This study is performed on healthy volunteers and drug concentration in plasma is determined..IRCT20200105046010N114Sajad darou shargh24